Roberto Machado completed his Internal Medicine residency and Chief Residency at Jackson Memorial, University of Miami. After his fellowship at the Cleveland Clinic, he completed research at the NIH. He was recruited to the University of Chicago and then to the University of Illinois Chicago, where he served as the Director of the Pulmonary Hypertension Program and the Outpatient Program. Roberto is a distinguished and internationally recognized researcher for his work on pulmonary vascular disease and the impact of genetic disorders, including sickle cell, to the disease.
“Roberto represents the innovative and committed new generation of investigators with tremendously bold ideas,” Department of Medicine Chair Mark Geraci said. “He has expertise in both clinical program development and research.”
Geraci said Machado’s vision is to expand the clinical, research and educational activities of the division along programamatic lines and expand the expertise to include a comprehensive approach to pulmonary and critical care medicine.
Machado succeeds Homer Twigg III, who has led the division for 17 years. Twigg will continue his outstanding work in the immunologic and microbiome bases of lung diseases, Geraci said.